{"id":"W4283701700","doi":"10.1016/j.ejca.2022.05.007","title":"Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 study","year":2022,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck Sharp and Dohme; Merck","keywords":"Pembrolizumab; Salivary gland; Medicine; Carcinoma; Oncology; Internal medicine; Pathology; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001672811,0.0001254615,0.000311906,0.0001837828,0.00003738165,0.000007553302,0.0001247846,0.000005671985,0.0001939199],"category_scores_gemma":[0.00002872189,0.00007163189,0.00005773818,0.000296777,0.00001761675,0.00006618128,0.00001567634,0.0001946698,5.436622e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002807571,"about_ca_system_score_gemma":0.0001742965,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001035139,"about_ca_topic_score_gemma":0.00005979806,"domain_scores_codex":[0.9968576,0.001394071,0.0004745453,0.0001334549,0.001009787,0.000130576],"domain_scores_gemma":[0.9990922,0.00004938543,0.0003703855,0.0001872129,0.0002566247,0.00004423763],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008290678,0.00498927,0.9543095,0.000007645602,0.0001526084,0.0004406696,0.004263853,0.00205006,0.000007703897,6.1547e-7,0.00008526319,0.02540212],"study_design_scores_gemma":[0.08310881,0.01197966,0.9033884,0.00009717873,0.0003908847,0.00002594444,0.0006472784,0.00008664075,0.00004467488,0.000003274456,0.0001635985,0.00006361379],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953544,0.002833109,7.708172e-7,0.0001793666,0.00006691168,0.001029875,0.00001252461,0.000002591795,0.0005204507],"genre_scores_gemma":[0.9996339,0.00008791383,0.00001308382,0.0001280805,0.00004860618,0.00004169811,0.00001015098,0.00002397006,0.0000125611],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07481813,"threshold_uncertainty_score":0.2921064,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02752118178310694,"score_gpt":0.3232095080446759,"score_spread":0.295688326261569,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}